Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein Structure, Tertiary | 34 | 2015 | 3792 | 1.610 |
Why?
|
Models, Molecular | 45 | 2024 | 5439 | 1.460 |
Why?
|
Crystallography, X-Ray | 36 | 2024 | 1990 | 1.260 |
Why?
|
Ubiquitin-Protein Ligases | 15 | 2015 | 1899 | 0.970 |
Why?
|
Ubiquitin | 9 | 2017 | 839 | 0.890 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 4 | 2015 | 286 | 0.830 |
Why?
|
Catalytic Domain | 12 | 2020 | 705 | 0.740 |
Why?
|
Protein Binding | 31 | 2024 | 9353 | 0.710 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 4 | 2015 | 88 | 0.710 |
Why?
|
Ubiquitin-Conjugating Enzymes | 6 | 2013 | 200 | 0.690 |
Why?
|
Amino Acid Sequence | 33 | 2021 | 13446 | 0.660 |
Why?
|
Endopeptidases | 4 | 2013 | 774 | 0.650 |
Why?
|
Peptidylprolyl Isomerase | 2 | 2010 | 97 | 0.650 |
Why?
|
Receptor Protein-Tyrosine Kinases | 4 | 2013 | 1626 | 0.620 |
Why?
|
Protein Structure, Secondary | 14 | 2013 | 1229 | 0.610 |
Why?
|
Binding Sites | 20 | 2024 | 6056 | 0.590 |
Why?
|
Adenosine Triphosphate | 5 | 2018 | 1989 | 0.570 |
Why?
|
Molecular Sequence Data | 30 | 2013 | 17635 | 0.560 |
Why?
|
Ubiquitin-Activating Enzymes | 3 | 2014 | 85 | 0.540 |
Why?
|
Protein Conformation | 18 | 2020 | 3968 | 0.470 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 4 | 2020 | 435 | 0.460 |
Why?
|
Nuclear Proteins | 10 | 2022 | 5799 | 0.460 |
Why?
|
Enzyme Inhibitors | 9 | 2021 | 3713 | 0.440 |
Why?
|
Cyclophilins | 2 | 2010 | 48 | 0.440 |
Why?
|
Small Molecule Libraries | 8 | 2021 | 733 | 0.430 |
Why?
|
Sequence Homology, Amino Acid | 14 | 2012 | 2748 | 0.430 |
Why?
|
Carbon-Nitrogen Lyases | 1 | 2012 | 8 | 0.410 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2012 | 91 | 0.410 |
Why?
|
Zinc Compounds | 1 | 2012 | 36 | 0.400 |
Why?
|
Proto-Oncogene Proteins | 6 | 2020 | 4513 | 0.390 |
Why?
|
Fluorides | 1 | 2012 | 134 | 0.380 |
Why?
|
Ubiquitination | 7 | 2020 | 1007 | 0.370 |
Why?
|
Transcription Factors | 13 | 2022 | 12129 | 0.360 |
Why?
|
Proline | 1 | 2012 | 457 | 0.360 |
Why?
|
Receptor, EphA1 | 1 | 2010 | 20 | 0.360 |
Why?
|
Biocatalysis | 2 | 2012 | 170 | 0.350 |
Why?
|
Ubiquitin Thiolesterase | 4 | 2017 | 455 | 0.350 |
Why?
|
Cell Cycle Proteins | 5 | 2023 | 3449 | 0.350 |
Why?
|
Chromatography, Affinity | 1 | 2011 | 532 | 0.350 |
Why?
|
Calpain | 2 | 2009 | 146 | 0.340 |
Why?
|
Ephrins | 1 | 2009 | 28 | 0.340 |
Why?
|
Protein Multimerization | 5 | 2015 | 983 | 0.330 |
Why?
|
Protease Inhibitors | 3 | 2020 | 754 | 0.330 |
Why?
|
Protein Folding | 4 | 2011 | 870 | 0.320 |
Why?
|
Histones | 3 | 2020 | 2580 | 0.320 |
Why?
|
DNA | 7 | 2024 | 7213 | 0.320 |
Why?
|
Drug Design | 7 | 2020 | 1048 | 0.320 |
Why?
|
Models, Chemical | 3 | 2009 | 611 | 0.310 |
Why?
|
Heterochromatin | 1 | 2011 | 293 | 0.310 |
Why?
|
Caspases | 1 | 2011 | 879 | 0.310 |
Why?
|
Structure-Activity Relationship | 13 | 2021 | 3076 | 0.300 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 6 | 2016 | 509 | 0.300 |
Why?
|
Sequence Alignment | 8 | 2013 | 2180 | 0.300 |
Why?
|
Receptors, Purinergic P2X7 | 2 | 2018 | 85 | 0.300 |
Why?
|
Neoplasm Proteins | 4 | 2022 | 3617 | 0.300 |
Why?
|
Ligands | 9 | 2022 | 3272 | 0.300 |
Why?
|
Recombinant Fusion Proteins | 5 | 2015 | 3733 | 0.300 |
Why?
|
Viral Vaccines | 2 | 2023 | 596 | 0.290 |
Why?
|
DNA-Binding Proteins | 11 | 2024 | 9610 | 0.290 |
Why?
|
Substrate Specificity | 7 | 2017 | 1791 | 0.280 |
Why?
|
Thiosulfate Sulfurtransferase | 1 | 2006 | 10 | 0.280 |
Why?
|
Multigene Family | 1 | 2010 | 1076 | 0.280 |
Why?
|
Cysteine | 4 | 2023 | 891 | 0.280 |
Why?
|
Repressor Proteins | 4 | 2024 | 2986 | 0.280 |
Why?
|
Adenosine Triphosphatases | 2 | 2015 | 836 | 0.270 |
Why?
|
Catalysis | 4 | 2013 | 774 | 0.270 |
Why?
|
Leukemia | 4 | 2017 | 1522 | 0.270 |
Why?
|
Protein Interaction Domains and Motifs | 4 | 2017 | 452 | 0.270 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2010 | 598 | 0.270 |
Why?
|
Oligopeptides | 4 | 2020 | 1187 | 0.260 |
Why?
|
Dimerization | 5 | 2012 | 891 | 0.260 |
Why?
|
Antineoplastic Agents | 10 | 2021 | 13642 | 0.260 |
Why?
|
Ubiquitins | 3 | 2020 | 366 | 0.260 |
Why?
|
Aluminum Hydroxide | 2 | 2022 | 54 | 0.250 |
Why?
|
Phosphoproteins | 5 | 2003 | 2448 | 0.250 |
Why?
|
Molecular Structure | 9 | 2021 | 1880 | 0.240 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2020 | 727 | 0.240 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2011 | 803 | 0.240 |
Why?
|
Nucleosomes | 3 | 2020 | 487 | 0.240 |
Why?
|
Multiprotein Complexes | 5 | 2013 | 1120 | 0.230 |
Why?
|
Benzbromarone | 1 | 2024 | 7 | 0.230 |
Why?
|
Azepines | 2 | 2016 | 329 | 0.220 |
Why?
|
Zinc Fingers | 2 | 2024 | 579 | 0.220 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2020 | 2917 | 0.220 |
Why?
|
Adaptor Proteins, Signal Transducing | 5 | 2015 | 2898 | 0.220 |
Why?
|
Thiophenes | 2 | 2017 | 569 | 0.210 |
Why?
|
CpG Islands | 3 | 2015 | 1230 | 0.210 |
Why?
|
Phenylalanine | 1 | 2004 | 366 | 0.210 |
Why?
|
HEK293 Cells | 11 | 2021 | 4280 | 0.210 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2004 | 305 | 0.210 |
Why?
|
Humans | 96 | 2024 | 761572 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2020 | 1406 | 0.200 |
Why?
|
Phosphotyrosine | 4 | 2013 | 456 | 0.200 |
Why?
|
Protein Kinase Inhibitors | 4 | 2020 | 5672 | 0.200 |
Why?
|
Protein Structure, Quaternary | 5 | 2012 | 429 | 0.200 |
Why?
|
Mannans | 1 | 2022 | 58 | 0.200 |
Why?
|
DNA Methylation | 3 | 2015 | 4399 | 0.200 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2020 | 8552 | 0.200 |
Why?
|
Protein Kinase C | 1 | 2006 | 1202 | 0.190 |
Why?
|
Proteins | 4 | 2022 | 6032 | 0.190 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2022 | 123 | 0.190 |
Why?
|
Hydrogen Bonding | 3 | 2011 | 291 | 0.190 |
Why?
|
Mutation | 14 | 2022 | 30054 | 0.190 |
Why?
|
Peptides | 4 | 2021 | 4358 | 0.190 |
Why?
|
CHO Cells | 3 | 2013 | 1387 | 0.190 |
Why?
|
Creatine Kinase | 1 | 2023 | 685 | 0.180 |
Why?
|
Molecular Conformation | 4 | 2011 | 544 | 0.180 |
Why?
|
Creatine | 1 | 2023 | 427 | 0.180 |
Why?
|
Animals | 37 | 2024 | 168467 | 0.180 |
Why?
|
Iron-Binding Proteins | 1 | 2000 | 79 | 0.180 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2020 | 293 | 0.180 |
Why?
|
Thiazolidines | 1 | 2020 | 69 | 0.180 |
Why?
|
Cell Proliferation | 11 | 2021 | 10448 | 0.180 |
Why?
|
Cell Line, Tumor | 16 | 2020 | 16986 | 0.170 |
Why?
|
Axonal Transport | 1 | 2021 | 178 | 0.170 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2009 | 1841 | 0.170 |
Why?
|
Tacrolimus Binding Proteins | 2 | 2013 | 194 | 0.170 |
Why?
|
Urea Cycle Disorders, Inborn | 1 | 2020 | 32 | 0.170 |
Why?
|
STAT5 Transcription Factor | 2 | 2019 | 265 | 0.170 |
Why?
|
Fibronectins | 1 | 2023 | 723 | 0.170 |
Why?
|
Recombinant Proteins | 7 | 2017 | 6534 | 0.170 |
Why?
|
Receptor, EphA3 | 2 | 2009 | 13 | 0.160 |
Why?
|
Leukemia, T-Cell | 1 | 2019 | 101 | 0.160 |
Why?
|
Serpins | 1 | 2020 | 247 | 0.160 |
Why?
|
Static Electricity | 2 | 2012 | 261 | 0.160 |
Why?
|
Cerebellar Neoplasms | 1 | 2024 | 586 | 0.160 |
Why?
|
Cysteine Endopeptidases | 2 | 2014 | 551 | 0.160 |
Why?
|
Sarcoma, Synovial | 1 | 2020 | 153 | 0.160 |
Why?
|
Genes, Essential | 1 | 2020 | 185 | 0.160 |
Why?
|
Candida albicans | 1 | 2022 | 372 | 0.160 |
Why?
|
Peptide Hydrolases | 2 | 2015 | 624 | 0.160 |
Why?
|
Saccharomyces cerevisiae | 1 | 2009 | 2688 | 0.160 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2012 | 698 | 0.160 |
Why?
|
Medulloblastoma | 1 | 2024 | 678 | 0.160 |
Why?
|
GTP Phosphohydrolases | 1 | 2022 | 517 | 0.160 |
Why?
|
Mitochondrial Diseases | 1 | 2022 | 343 | 0.150 |
Why?
|
Apoproteins | 1 | 2017 | 45 | 0.150 |
Why?
|
Disulfides | 1 | 2020 | 465 | 0.150 |
Why?
|
Mice | 22 | 2024 | 81533 | 0.150 |
Why?
|
Urea | 1 | 2020 | 443 | 0.150 |
Why?
|
Loss of Heterozygosity | 1 | 2020 | 662 | 0.150 |
Why?
|
Antigens, Viral | 1 | 2022 | 988 | 0.150 |
Why?
|
Lactic Acid | 1 | 2023 | 1139 | 0.150 |
Why?
|
Signal Transduction | 9 | 2023 | 23447 | 0.150 |
Why?
|
Phosphorylation | 9 | 2021 | 8321 | 0.140 |
Why?
|
beta Catenin | 1 | 2022 | 1040 | 0.140 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2020 | 1351 | 0.140 |
Why?
|
Lymphoma, T-Cell | 1 | 2019 | 304 | 0.140 |
Why?
|
Arginine | 1 | 2020 | 934 | 0.130 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 1036 | 0.130 |
Why?
|
Cell Cycle | 2 | 2023 | 2932 | 0.130 |
Why?
|
Apoptosis | 7 | 2021 | 9489 | 0.130 |
Why?
|
2-Aminopurine | 1 | 2015 | 11 | 0.130 |
Why?
|
Evolution, Molecular | 3 | 2016 | 1886 | 0.130 |
Why?
|
Cell Communication | 1 | 2023 | 1657 | 0.130 |
Why?
|
Cloning, Molecular | 4 | 2017 | 4174 | 0.130 |
Why?
|
Mass Spectrometry | 2 | 2014 | 2192 | 0.130 |
Why?
|
Transcriptional Elongation Factors | 1 | 2017 | 165 | 0.130 |
Why?
|
Amino Acids | 2 | 2012 | 1718 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2021 | 988 | 0.130 |
Why?
|
Tretinoin | 1 | 2018 | 519 | 0.130 |
Why?
|
Phthalimides | 1 | 2015 | 34 | 0.120 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2019 | 634 | 0.120 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2011 | 1693 | 0.120 |
Why?
|
Mevalonic Acid | 1 | 1994 | 46 | 0.120 |
Why?
|
Carboxy-Lyases | 1 | 1994 | 85 | 0.120 |
Why?
|
Escherichia coli | 6 | 2017 | 4217 | 0.120 |
Why?
|
Fatty Acids | 1 | 2002 | 1808 | 0.120 |
Why?
|
Fluorescence Recovery After Photobleaching | 1 | 2014 | 54 | 0.120 |
Why?
|
Carrier Proteins | 4 | 2018 | 4937 | 0.110 |
Why?
|
Cyclopentanes | 1 | 2014 | 87 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2020 | 368 | 0.110 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2017 | 495 | 0.110 |
Why?
|
Protein Processing, Post-Translational | 3 | 2011 | 1974 | 0.110 |
Why?
|
Publications | 1 | 2016 | 194 | 0.110 |
Why?
|
High-Throughput Screening Assays | 2 | 2020 | 934 | 0.110 |
Why?
|
Histidine | 2 | 2011 | 308 | 0.110 |
Why?
|
Macromolecular Substances | 1 | 2016 | 1434 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 2018 | 3769 | 0.110 |
Why?
|
Pyrimidines | 2 | 2016 | 3028 | 0.110 |
Why?
|
Th2 Cells | 1 | 2018 | 1060 | 0.110 |
Why?
|
Protein Subunits | 2 | 2022 | 943 | 0.110 |
Why?
|
Insulin-Secreting Cells | 1 | 2020 | 901 | 0.100 |
Why?
|
Axons | 1 | 2021 | 1674 | 0.100 |
Why?
|
Catechin | 1 | 2012 | 69 | 0.100 |
Why?
|
Immediate-Early Proteins | 1 | 2015 | 449 | 0.100 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2013 | 135 | 0.100 |
Why?
|
Blotting, Western | 4 | 2017 | 5035 | 0.100 |
Why?
|
Tandem Mass Spectrometry | 2 | 2016 | 1188 | 0.100 |
Why?
|
Opioid Peptides | 1 | 2012 | 37 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1609 | 0.100 |
Why?
|
HeLa Cells | 2 | 2019 | 3094 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2017 | 2872 | 0.100 |
Why?
|
Ubiquitinated Proteins | 1 | 2011 | 32 | 0.100 |
Why?
|
Herpes Simplex | 1 | 2015 | 478 | 0.100 |
Why?
|
Kinetics | 5 | 2013 | 6374 | 0.100 |
Why?
|
Peptide Fragments | 2 | 2017 | 5112 | 0.100 |
Why?
|
Methyltransferases | 1 | 2015 | 377 | 0.100 |
Why?
|
Cricetulus | 1 | 2013 | 814 | 0.100 |
Why?
|
Th17 Cells | 1 | 2018 | 794 | 0.100 |
Why?
|
Proteomics | 3 | 2018 | 3848 | 0.100 |
Why?
|
Cell Survival | 5 | 2021 | 5791 | 0.100 |
Why?
|
Entropy | 1 | 2012 | 210 | 0.100 |
Why?
|
Transformation, Bacterial | 1 | 2011 | 76 | 0.090 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 2012 | 182 | 0.090 |
Why?
|
Centrifugation | 1 | 2011 | 122 | 0.090 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2012 | 141 | 0.090 |
Why?
|
Quinolines | 1 | 2016 | 764 | 0.090 |
Why?
|
Triazoles | 1 | 2016 | 903 | 0.090 |
Why?
|
src Homology Domains | 5 | 2019 | 361 | 0.090 |
Why?
|
Crystallization | 2 | 2012 | 534 | 0.090 |
Why?
|
Ligases | 1 | 2012 | 333 | 0.090 |
Why?
|
DNA Replication | 2 | 2015 | 1418 | 0.090 |
Why?
|
Ephrin-A5 | 1 | 2010 | 17 | 0.090 |
Why?
|
RNA | 1 | 2021 | 2726 | 0.090 |
Why?
|
Ephrin-A1 | 1 | 2010 | 9 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2021 | 10766 | 0.090 |
Why?
|
Cricetinae | 2 | 2012 | 2423 | 0.090 |
Why?
|
Receptor, EphA2 | 1 | 2010 | 41 | 0.090 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 1 | 2011 | 170 | 0.090 |
Why?
|
Sulfonamides | 1 | 2020 | 1978 | 0.090 |
Why?
|
src-Family Kinases | 1 | 2013 | 535 | 0.090 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2021 | 718 | 0.090 |
Why?
|
Silicon Dioxide | 1 | 2011 | 216 | 0.090 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2020 | 3615 | 0.090 |
Why?
|
Retinal Pigment Epithelium | 1 | 2013 | 303 | 0.080 |
Why?
|
Thalidomide | 1 | 2015 | 885 | 0.080 |
Why?
|
Herpesvirus 1, Human | 1 | 2015 | 753 | 0.080 |
Why?
|
Crystallography | 2 | 2007 | 116 | 0.080 |
Why?
|
Fluorescence Polarization | 1 | 2009 | 140 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2023 | 3963 | 0.080 |
Why?
|
Receptors, Eph Family | 1 | 2009 | 45 | 0.080 |
Why?
|
Eye Proteins | 1 | 2013 | 633 | 0.080 |
Why?
|
Enzyme Activation | 6 | 2014 | 3597 | 0.080 |
Why?
|
Neoplasms, Experimental | 3 | 2021 | 1229 | 0.080 |
Why?
|
Surface Properties | 1 | 2012 | 1161 | 0.080 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2018 | 1321 | 0.080 |
Why?
|
Databases, Genetic | 1 | 2016 | 1742 | 0.080 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2014 | 1334 | 0.080 |
Why?
|
Antibodies, Neutralizing | 3 | 2023 | 1943 | 0.080 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 506 | 0.080 |
Why?
|
Immunoglobulins | 1 | 2011 | 852 | 0.080 |
Why?
|
Genes, Tumor Suppressor | 1 | 2012 | 1062 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2422 | 0.080 |
Why?
|
Glucose | 1 | 2020 | 4346 | 0.080 |
Why?
|
Chemistry, Physical | 1 | 2008 | 154 | 0.080 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2009 | 274 | 0.080 |
Why?
|
Chemical Fractionation | 1 | 2008 | 61 | 0.080 |
Why?
|
Pyridines | 1 | 2020 | 2875 | 0.080 |
Why?
|
Peptide Library | 1 | 2009 | 347 | 0.080 |
Why?
|
5-Methylcytosine | 1 | 2008 | 148 | 0.070 |
Why?
|
Plasmids | 2 | 2011 | 2269 | 0.070 |
Why?
|
Glioma | 1 | 2022 | 3455 | 0.070 |
Why?
|
DNA Mutational Analysis | 3 | 2014 | 4111 | 0.070 |
Why?
|
Spliceosomes | 1 | 2008 | 130 | 0.070 |
Why?
|
Zinc | 1 | 2011 | 690 | 0.070 |
Why?
|
Cell Line | 5 | 2015 | 15601 | 0.070 |
Why?
|
Histone Deacetylases | 1 | 2011 | 720 | 0.070 |
Why?
|
Antibodies, Viral | 3 | 2023 | 3156 | 0.070 |
Why?
|
Phagocytosis | 2 | 2013 | 1528 | 0.070 |
Why?
|
Drug Discovery | 3 | 2020 | 1051 | 0.070 |
Why?
|
Mammals | 2 | 2022 | 1132 | 0.070 |
Why?
|
Mice, Inbred BALB C | 3 | 2022 | 6214 | 0.070 |
Why?
|
Neoplasms | 3 | 2020 | 22173 | 0.070 |
Why?
|
Protein Isoforms | 3 | 2023 | 1699 | 0.070 |
Why?
|
Gene Knockdown Techniques | 3 | 2017 | 1612 | 0.070 |
Why?
|
Genetic Vectors | 2 | 2017 | 3396 | 0.070 |
Why?
|
Biphenyl Compounds | 1 | 2011 | 1007 | 0.070 |
Why?
|
Pyrazoles | 1 | 2016 | 2009 | 0.070 |
Why?
|
Lipase | 1 | 2008 | 325 | 0.070 |
Why?
|
DNA Repair | 1 | 2015 | 2046 | 0.070 |
Why?
|
Tyrosine | 2 | 2008 | 1440 | 0.070 |
Why?
|
Spectrum Analysis, Raman | 1 | 2008 | 237 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2014 | 1903 | 0.060 |
Why?
|
Multiple Myeloma | 2 | 2017 | 5146 | 0.060 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2006 | 150 | 0.060 |
Why?
|
Epinephrine | 1 | 2008 | 792 | 0.060 |
Why?
|
Leukemia, Promyelocytic, Acute | 2 | 2018 | 251 | 0.060 |
Why?
|
Graft Rejection | 1 | 2018 | 4446 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4652 | 0.060 |
Why?
|
Amino Acid Motifs | 2 | 2021 | 931 | 0.060 |
Why?
|
Reactive Oxygen Species | 1 | 2012 | 2141 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2018 | 4580 | 0.060 |
Why?
|
Heart Transplantation | 1 | 2018 | 3233 | 0.060 |
Why?
|
Solutions | 2 | 2016 | 412 | 0.060 |
Why?
|
Phylogeny | 1 | 2012 | 2811 | 0.060 |
Why?
|
Protein Kinases | 2 | 2016 | 1608 | 0.060 |
Why?
|
Homeostasis | 2 | 2022 | 3323 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2017 | 7593 | 0.060 |
Why?
|
Protein Engineering | 1 | 2008 | 549 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 11904 | 0.060 |
Why?
|
Inflammation | 2 | 2022 | 10773 | 0.060 |
Why?
|
gamma-Globins | 1 | 2024 | 106 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2020 | 7858 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3415 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2018 | 1827 | 0.050 |
Why?
|
Immune System | 1 | 2008 | 796 | 0.050 |
Why?
|
Base Sequence | 2 | 2012 | 12441 | 0.050 |
Why?
|
Anaphase | 1 | 2023 | 114 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2023 | 12794 | 0.050 |
Why?
|
Rats | 5 | 2021 | 23741 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2024 | 9031 | 0.050 |
Why?
|
Annelida | 1 | 2002 | 7 | 0.050 |
Why?
|
Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2022 | 49 | 0.050 |
Why?
|
Lamins | 1 | 2002 | 37 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2803 | 0.050 |
Why?
|
Transcription Factor RelB | 1 | 2022 | 28 | 0.050 |
Why?
|
Anura | 1 | 2002 | 80 | 0.050 |
Why?
|
Mesalamine | 1 | 2023 | 135 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6935 | 0.050 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2002 | 126 | 0.050 |
Why?
|
Diptera | 1 | 2002 | 50 | 0.050 |
Why?
|
Phosphotransferases | 1 | 2023 | 303 | 0.050 |
Why?
|
Molecular Targeted Therapy | 3 | 2020 | 2811 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6132 | 0.050 |
Why?
|
Water | 1 | 2008 | 1411 | 0.050 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2017 | 682 | 0.050 |
Why?
|
Conserved Sequence | 2 | 2016 | 1163 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2011 | 4415 | 0.050 |
Why?
|
Guanosine Triphosphate | 1 | 2022 | 316 | 0.050 |
Why?
|
beta-Glucans | 1 | 2022 | 123 | 0.050 |
Why?
|
Lamin Type A | 1 | 2002 | 189 | 0.050 |
Why?
|
Vero Cells | 1 | 2022 | 482 | 0.050 |
Why?
|
Lipodystrophy | 1 | 2002 | 145 | 0.050 |
Why?
|
Mutagenesis | 2 | 2018 | 1232 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2018 | 14416 | 0.040 |
Why?
|
Pyruvate Carboxylase | 1 | 2020 | 17 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2017 | 3801 | 0.040 |
Why?
|
Models, Biological | 3 | 2013 | 9469 | 0.040 |
Why?
|
Solubility | 1 | 2022 | 1091 | 0.040 |
Why?
|
Friedreich Ataxia | 1 | 2000 | 77 | 0.040 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 1999 | 557 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2002 | 318 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2022 | 1060 | 0.040 |
Why?
|
DNA Primase | 1 | 2020 | 110 | 0.040 |
Why?
|
Muscular Dystrophies | 1 | 2002 | 390 | 0.040 |
Why?
|
Nucleotides | 1 | 2022 | 454 | 0.040 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2020 | 1551 | 0.040 |
Why?
|
Paranasal Sinuses | 1 | 2022 | 265 | 0.040 |
Why?
|
Hedgehog Proteins | 1 | 2024 | 768 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12148 | 0.040 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 1 | 1999 | 124 | 0.040 |
Why?
|
Granzymes | 1 | 2020 | 277 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 616 | 0.040 |
Why?
|
Citric Acid Cycle | 1 | 2020 | 231 | 0.040 |
Why?
|
Glycosylation | 2 | 2015 | 1097 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2014 | 5305 | 0.040 |
Why?
|
Fishes | 1 | 2002 | 603 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2022 | 585 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2022 | 22172 | 0.040 |
Why?
|
NIH 3T3 Cells | 1 | 2020 | 670 | 0.040 |
Why?
|
Cytoplasmic Granules | 1 | 2021 | 574 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 706 | 0.040 |
Why?
|
Tryptophan | 1 | 2020 | 482 | 0.040 |
Why?
|
Ganglia, Spinal | 1 | 2021 | 526 | 0.040 |
Why?
|
Muscular Diseases | 1 | 2022 | 553 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 858 | 0.040 |
Why?
|
Aspartic Acid | 1 | 2020 | 576 | 0.040 |
Why?
|
Mutant Proteins | 1 | 2019 | 491 | 0.040 |
Why?
|
Mitosis | 1 | 2023 | 1188 | 0.040 |
Why?
|
Immunization | 1 | 2022 | 1227 | 0.040 |
Why?
|
DNA Helicases | 1 | 2022 | 851 | 0.040 |
Why?
|
Lipids | 1 | 2008 | 3341 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1756 | 0.030 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 398 | 0.030 |
Why?
|
3T3 Cells | 1 | 2018 | 1085 | 0.030 |
Why?
|
Protein Interaction Mapping | 2 | 2011 | 616 | 0.030 |
Why?
|
Sensory Receptor Cells | 1 | 2021 | 513 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 1998 | 457 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2020 | 1739 | 0.030 |
Why?
|
Tacrolimus Binding Protein 1A | 1 | 2015 | 40 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2021 | 1076 | 0.030 |
Why?
|
Shal Potassium Channels | 1 | 2015 | 20 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2503 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1330 | 0.030 |
Why?
|
Neoplastic Stem Cells | 1 | 2022 | 1349 | 0.030 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2015 | 283 | 0.030 |
Why?
|
Immunity | 1 | 2020 | 996 | 0.030 |
Why?
|
Thrombosis | 1 | 2008 | 2942 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2018 | 2016 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 802 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2022 | 2385 | 0.030 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 305 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2020 | 21017 | 0.030 |
Why?
|
U937 Cells | 1 | 2014 | 261 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2023 | 18253 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2016 | 437 | 0.030 |
Why?
|
S-Adenosylmethionine | 1 | 2015 | 218 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2018 | 5485 | 0.030 |
Why?
|
Protein Stability | 1 | 2015 | 578 | 0.030 |
Why?
|
Rod Cell Outer Segment | 1 | 2013 | 51 | 0.030 |
Why?
|
Cullin Proteins | 1 | 2014 | 179 | 0.030 |
Why?
|
GRB2 Adaptor Protein | 1 | 2013 | 101 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2665 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2904 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2013 | 91 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 1363 | 0.030 |
Why?
|
Computer Simulation | 1 | 2006 | 6241 | 0.030 |
Why?
|
Calmodulin | 1 | 2013 | 218 | 0.030 |
Why?
|
Heterozygote | 1 | 2019 | 2787 | 0.030 |
Why?
|
RNA Polymerase II | 1 | 2017 | 539 | 0.030 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2013 | 77 | 0.030 |
Why?
|
K562 Cells | 1 | 2014 | 642 | 0.030 |
Why?
|
Receptor, Insulin | 1 | 1996 | 836 | 0.030 |
Why?
|
Calorimetry | 1 | 2012 | 129 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1745 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1084 | 0.020 |
Why?
|
Iron | 1 | 2000 | 1793 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2012 | 174 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2015 | 529 | 0.020 |
Why?
|
RING Finger Domains | 1 | 2010 | 7 | 0.020 |
Why?
|
Molecular Weight | 1 | 2013 | 2186 | 0.020 |
Why?
|
Allosteric Site | 1 | 2011 | 103 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1897 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2020 | 2135 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2012 | 740 | 0.020 |
Why?
|
Triticum | 1 | 2011 | 90 | 0.020 |
Why?
|
Protein Denaturation | 1 | 2011 | 242 | 0.020 |
Why?
|
Adenine | 1 | 2016 | 987 | 0.020 |
Why?
|
Pyrroles | 1 | 2017 | 1125 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1659 | 0.020 |
Why?
|
Choroid | 1 | 2013 | 360 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2827 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2022 | 3466 | 0.020 |
Why?
|
Autoimmunity | 1 | 2018 | 1356 | 0.020 |
Why?
|
Female | 8 | 2021 | 392686 | 0.020 |
Why?
|
Cyclin D3 | 1 | 2010 | 54 | 0.020 |
Why?
|
Models, Genetic | 1 | 2020 | 3442 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3384 | 0.020 |
Why?
|
Adenosine | 1 | 2015 | 808 | 0.020 |
Why?
|
Hematopoietic System | 1 | 2010 | 110 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 1741 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2022 | 3066 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 8181 | 0.020 |
Why?
|
Trypsin | 1 | 2010 | 495 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2022 | 10194 | 0.020 |
Why?
|
Paraoxon | 1 | 2008 | 3 | 0.020 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1728 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6864 | 0.020 |
Why?
|
Immunophilins | 1 | 2008 | 20 | 0.020 |
Why?
|
Chickens | 1 | 2011 | 859 | 0.020 |
Why?
|
Genome | 1 | 2017 | 1740 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2009 | 269 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3430 | 0.020 |
Why?
|
Point Mutation | 1 | 2014 | 1595 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2022 | 4758 | 0.020 |
Why?
|
Insulin | 1 | 2003 | 6597 | 0.020 |
Why?
|
Cryoelectron Microscopy | 1 | 2012 | 650 | 0.020 |
Why?
|
Thiolester Hydrolases | 1 | 2009 | 90 | 0.020 |
Why?
|
Piperidines | 1 | 2016 | 1656 | 0.020 |
Why?
|
Yeasts | 1 | 2009 | 279 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4141 | 0.020 |
Why?
|
Cytosol | 1 | 2011 | 888 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2018 | 5869 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3877 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2017 | 1589 | 0.020 |
Why?
|
Lysine | 1 | 2012 | 993 | 0.020 |
Why?
|
Culture Media | 1 | 2009 | 897 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3624 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2019 | 1896 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2012 | 5790 | 0.020 |
Why?
|
Niacinamide | 1 | 2009 | 413 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5769 | 0.020 |
Why?
|
Cholinesterase Inhibitors | 1 | 2008 | 242 | 0.020 |
Why?
|
DNA Damage | 1 | 2016 | 2449 | 0.020 |
Why?
|
Research Design | 1 | 2022 | 6180 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9541 | 0.020 |
Why?
|
Genome, Human | 1 | 2019 | 4425 | 0.020 |
Why?
|
Rabbits | 1 | 2012 | 4772 | 0.020 |
Why?
|
Models, Immunological | 1 | 2008 | 513 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 1967 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2226 | 0.020 |
Why?
|
Down-Regulation | 1 | 2012 | 2919 | 0.020 |
Why?
|
Diet | 1 | 2023 | 8075 | 0.020 |
Why?
|
Gene Expression | 1 | 2017 | 7581 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2065 | 0.020 |
Why?
|
Tacrolimus | 1 | 2008 | 733 | 0.010 |
Why?
|
Milk Proteins | 1 | 2005 | 163 | 0.010 |
Why?
|
Cell Death | 1 | 2010 | 1679 | 0.010 |
Why?
|
Two-Hybrid System Techniques | 1 | 2005 | 460 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2002 | 5841 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2010 | 1134 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 2008 | 754 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3093 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13510 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2009 | 18965 | 0.010 |
Why?
|
Vanadates | 1 | 2003 | 82 | 0.010 |
Why?
|
Benzamides | 1 | 2009 | 1370 | 0.010 |
Why?
|
Lung | 1 | 2022 | 10002 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 1 | 1 | 2002 | 27 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2645 | 0.010 |
Why?
|
POU Domain Factors | 1 | 2002 | 47 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2015 | 3677 | 0.010 |
Why?
|
Neurons | 2 | 2015 | 9463 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2002 | 92 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5369 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2003 | 813 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9420 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2010 | 1403 | 0.010 |
Why?
|
Melanoma | 1 | 2020 | 5709 | 0.010 |
Why?
|
X-Ray Diffraction | 1 | 2002 | 421 | 0.010 |
Why?
|
Software | 1 | 2016 | 4434 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8656 | 0.010 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2002 | 174 | 0.010 |
Why?
|
Janus Kinase 2 | 1 | 2005 | 560 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26127 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2012 | 3492 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 1545 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12947 | 0.010 |
Why?
|
Codon | 1 | 2002 | 601 | 0.010 |
Why?
|
Calcium | 1 | 2013 | 5722 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 1991 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12990 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2003 | 2264 | 0.010 |
Why?
|
SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 1998 | 43 | 0.010 |
Why?
|
Aged | 2 | 2022 | 169310 | 0.010 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 1998 | 120 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2008 | 3113 | 0.010 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 1998 | 223 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2023 | 64684 | 0.010 |
Why?
|
Peptide Mapping | 1 | 1996 | 262 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29629 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2003 | 1486 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 2425 | 0.010 |
Why?
|
Child | 1 | 2024 | 80156 | 0.010 |
Why?
|
Stem Cells | 1 | 2008 | 3523 | 0.010 |
Why?
|
Trans-Activators | 1 | 2005 | 2856 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 5774 | 0.010 |
Why?
|
Time Factors | 2 | 2010 | 39970 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2008 | 3049 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59255 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2002 | 2571 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 88324 | 0.010 |
Why?
|
Male | 2 | 2020 | 360842 | 0.010 |
Why?
|
Kidney | 1 | 2003 | 7047 | 0.000 |
Why?
|
Liver | 1 | 2003 | 7529 | 0.000 |
Why?
|
Middle Aged | 1 | 2020 | 220920 | 0.000 |
Why?
|
Adult | 1 | 2020 | 221203 | 0.000 |
Why?
|